Total Funding
84
92
Total FundingSeries B raised
Growth Score
5 pts
Heat Score
34 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
13361
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
- Stephen Bloch: Co-Founder and CEOPast Role: OmniSonics Medical Technologies, Team Member
- Stephen M. Strittmatter: Co-Founder
About the Company
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug capable of delivering a disease-modifying approach and preserving cognition in
patients.
